Sign in to continue:

Monday, March 9th, 2026

Author: Minichart

us corporate news

Duke Energy Equity Distribution Agreement: Key Terms, Agents, and Forward Sale Details

Minichart
March 7, 2026

Duke Energy Corporation Equity Distribution Agreement: Key Details for Investors Duke Energy Announces \$6 Billion Equity Distribution Program – Key Details for Investors Overview Duke Energy Corporation has entered into a comprehensive Equity Distribution...

Continue Reading 0
us corporate news

Stem, Inc. and Jefferies LLC Enter Open Market Sales Agreement for Common Stock – Key Terms, Legal Details, and XBRL Filings (March 2026) 82647

Minichart
March 7, 2026

Stem, Inc. Files Form 8-K: Key Details on At-the-Market Equity Offering Stem, Inc. Announces At-the-Market Equity Offering: Key Investor Insights Stem, Inc. has filed a Current Report on Form 8-K with the U.S. Securities...

Continue Reading 0
us corporate news

Canadian Pacific Kansas City Limited $600 Million Notes Offering: Underwriting Agreement, Significant Subsidiaries, and Supplemental Indenture Details 6 51 57

Minichart
March 7, 2026

Canadian Pacific Kansas City Limited: Key Financial and Corporate Developments Canadian Pacific Kansas City Limited: Key Financial and Corporate Developments Executive Summary Canadian Pacific Kansas City Limited (CPKC) and its wholly-owned subsidiary, Canadian Pacific...

Continue Reading 0
us corporate news

Interactive Strength Inc. (TRNR) Files 8-K SEC Report – Company Information, Legal Opinion, and XBRL Data (March 6, 2026)

Minichart
March 7, 2026

Interactive Strength Inc. Increases ATM Offering – Key Details for Investors Interactive Strength Inc. Announces Significant Increase in At-The-Market Offering Interactive Strength Inc. (NASDAQ: TRNR) has made a major announcement that could be of...

Continue Reading 0
us corporate news

TOMI Environmental Solutions, Inc. Form 8-K Filing Details, NASDAQ Listing, and Company Information (2026)

Minichart
March 7, 2026

TOMI Environmental Solutions, Inc. – Key Investor Update (8-K Filing, March 2026) TOMI Environmental Solutions, Inc. Announces Potential \$20 Million Equity Sale – Key Shareholder Update Overview TOMI Environmental Solutions, Inc. (Nasdaq: TOMZ) filed...

Continue Reading 0
us corporate news

Vicarious Surgical Inc. 8-K Filing March 2026: Executive Employment Agreement Amendments and Corporate Details

Minichart
March 7, 2026

Vicarious Surgical Inc. Files 8-K: Key Investor Insights Vicarious Surgical Inc. (NYSE: RBOT) Files Form 8-K: Detailed Investor Update Vicarious Surgical Inc. has filed a Form 8-K with the SEC, dated March 4, 2026....

Continue Reading 0
us corporate news

Purchase and Sale Agreement Key Terms: Environmental Audit, Title Review, Closing, and Due Diligence Explained

Minichart
March 7, 2026

Medalist Diversified REIT, Inc. SEC 8-K Filing Analysis Medalist Diversified REIT, Inc. (Nasdaq: MDRR) Announces Entry Into Material Definitive Agreement Date of Report: March 6, 2026 Earliest Event Reported: March 5, 2026 Form: 8-K...

Continue Reading 0
us corporate news

Alzamend Neuro Enters At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC – SEC 8-K Filing Details

Minichart
March 7, 2026

Alzamend Neuro, Inc. Announces At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC Atlanta, GA – March 6, 2026 – Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company, has entered into a significant...

Continue Reading 0
us corporate news

bioAffinity Technologies, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Trading Symbols (March 5, 2026)

Minichart
March 7, 2026

bioAffinity Technologies, Inc. Files Form 8-K: Key Details Investors Should Know San Antonio, TX, March 6, 2026 — bioAffinity Technologies, Inc. (“the Company”), a San Antonio-based biotechnology firm, has filed a Form 8-K with...

Continue Reading 0
us corporate news

Curanex Pharmaceuticals Executive Employment Agreements and Proprietary Information Assignment – SEC Filing Details

Minichart
March 7, 2026

Curanex Pharmaceuticals Inc. Form 8-K Detailed Investor Report Curanex Pharmaceuticals Inc. Files Key Executive Agreements: Detailed Investor Analysis Key Points from the Form 8-K Filing Curanex Pharmaceuticals Inc. (NASDAQ: CURX) has filed a Form...

Continue Reading 0